SW · MEDX.SW
medmix AG
- Sector
- Industrials · Industrial - Machinery
- Headquarters
- Zug 6300
- Website
- medmix.swiss
Price · as of 2025-12-31
$8.32
Market cap 384.52M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $29.39 | +253.25% |
| Intrinsic Value(DCF) | $4.42 | -46.88% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $0.17 | -98.02% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $0.00 | $0.64 | |||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $24.81 | $27.02 | $10.15 | $0.00 | $39.62 |
| 2022 | $15.95 | $29.73 | $6.94 | $2.04 | $3.50 |
| 2023 | $13.66 | $23.44 | $1.39 | $0.00 | $0.07 |
| 2024 | $10.35 | $55.54 | $0.56 | $0.00 | $0.00 |
| 2025 | $9.42 | $29.39 | $1.10 | $0.00 | $0.17 |
AI valuation
Our deep-learning model estimates medmix AG's (MEDX.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $29.39
- Current price
- $8.32
- AI upside
- +253.25%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$4.42
-46.88% upside
Graham-Dodd
—
— upside
Graham Formula
$0.17
-98.02% upside
About medmix AG
Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.
- CEO
- Jennifer Dean
- Employees
- 2.68K
- Beta
- 0.93
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($4.42 ÷ $8.32) − 1 = -46.88% (DCF, example).